Safety of bisphosphonates.

Safety of bisphosphonates.

Bisphosphonates are one of the most well studied groups of medications and they are bone specific. This tissue specificity is a rare property for a drug introduced into clinical practice as long as 40 years ago. Over the years, the therapeutic boundaries of bisphosphonates were explored and their sa...

書誌詳細
主要な著者:	Pazianas, M, Abrahamsen, B
フォーマット:	Journal article
言語:	English
出版事項:	2011

類似資料

Safety issues with bisphosphonate therapy for osteoporosis.
著者:: Suresh, E, 等
出版事項: (2014)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
著者:: Pazianas, M, 等
出版事項: (2014)

Eliminating the need for fasting with oral administration of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
著者:: Pazianas M, 等
出版事項: (2013-10-01)

Bisphosphonates and colon cancer: reply.
著者:: Pazianas, M, 等
出版事項: (2013)

Bisphosphonates and colon cancer: Reply
著者:: Pazianas, M, 等
出版事項: (2013)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
著者:: Abrahamsen, B, 等
出版事項: (2013)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
著者:: Pazianas, M, 等
出版事項: (2010)

Evaluating the antifracture efficacy of bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2009)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
著者:: Pazianas, M, 等
出版事項: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
著者:: Pazianas, M, 等
出版事項: (2013)

Bisphosphonates and bone quality.
著者:: Pazianas, M, 等
出版事項: (2014)

Atrial fibrillation and bisphosphonate therapy.
著者:: Pazianas, M, 等
出版事項: (2010)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
著者:: Pazianas, M, 等
出版事項: (2012)

Potential therapeutic effects of oral bisphosphonates on the intestine.
著者:: Pazianas, M, 等
出版事項: (2011)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
著者:: Pazianas, M
出版事項: (2013)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
著者:: Michael Pazianas
出版事項: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates
著者:: Michael Pazianas, 等
出版事項: (2011-03-01)

Atrial fibrillation and the use of oral bisphosphonates.
著者:: Pazianas, M, 等
出版事項: (2011)

Oral bisphosphonates and chronic kidney disease: progression and safety
著者:: Prieto-Alhambra, D, 等
出版事項: (2018)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
著者:: Pazianas, M, 等
出版事項: (2010)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
著者:: Pazianas, M, 等
出版事項: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
著者:: Pazianas, M, 等
出版事項: (2008)

A NEPHROLOGIST’S VIEW TO RENAL SAFETY OF BISPHOSPHONATES
著者:: Sevgi Şahin
出版事項: (2007-07-01)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
著者:: Abrahamsen, B, 等
出版事項: (2016)

BISPHOSPHONATE USE AND IMPROVED IMPLANT SURVIVAL: A NATIONWIDE COHORT STUDY
著者:: Alhambra, D, 等
出版事項: (2013)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
著者:: Robinson, DE, 等
出版事項: (2021)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
著者:: Pazianas, M, 等
出版事項: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
著者:: Sujata Sharma, 等
出版事項: (2023-04-01)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
著者:: Garriga, C, 等
出版事項: (2018)

Bisphosphonates
著者:: Bishop, N, 等
出版事項: (2013)

Bisphosphonates
著者:: Fırat Öztürk
出版事項: (2009-04-01)

BISPHOSPHONATE USE AND IMPROVED IMPLANT SURVIVAL: A NATION-WIDE COHORT STUDY
著者:: Prieto-Alhambra, D, 等
出版事項: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
著者:: Garriga, C, 等
出版事項: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
著者:: Garriga, C, 等
出版事項: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
著者:: Garriga, C, 等
出版事項: (2017)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
著者:: Luca Dalle Carbonare, 等
出版事項: (2010-08-01)

Bisphosphonates: An update
著者:: Nalliappan Ganapathy, 等
出版事項: (2012-01-01)

Bisphosphonates 2006
著者:: Russell, R
出版事項: (2006)

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
著者:: Rodriguez, AJ, 等
出版事項: (2020)